Abstract
The objective of the study was to investigate the association between peptidylarginine deiminase 4 (PADI4) polymorphism and susceptibility to rheumatoid arthritis (RA). An electronic searching strategy was employed to collect relevant studies on the association between PADI4 polymorphism and susceptibility to RA. The odds ratio (OR) with the 95 % confidence interval (95 % CI) was used to evaluate the RA risk presented by PADI4 polymorphism. Fixed or random effects models were selected based on heterogeneity. Publication bias was assessed using funnel plots, Begg’s test, and Egger’s test. A total of 27 studies from 21 articles were included. Six gene loci (padi4_94, 104, 92, 90, 89, and 100) were chosen for the meta-analysis. The pooled ORs (95 % CI) for allele 2 versus 1 were 1.08 (1.05–1.12), 1.17 (1.12–1.23), 1.26 (1.18–1.36), 1.17 (1.10–1.24), 1.30 (1.17–1.44), and 1.25 (1.11–1.40), respectively. All six SNPs were significantly associated with RA in Asian populations. Three SNPs (PADI4_104, 90, 89) showed significant associations, while the other three SNPs (PADI4_94, 92, 100) exhibited no associations in the European population. A dose–response relationship between allele 2 of PADI4 and the risk of RA was also identified. In conclusion, this meta-analysis suggests that PADI4 polymorphisms represent a significant risk factor for RA, especially in Asians.
Similar content being viewed by others
References
Perricone C, Ceccarelli F, Valesini G. An overview on the genetic of rheumatoid arthritis: a never-ending story. Autoimmun Rev. 2011;10:599–608.
Harris ED Jr. Rheumatoid arthritis. Pathophysiology and implications for therapy. N Engl J Med. 1990;322:1277–89.
Dieudé P, Cornélis F. Genetic basis of rheumatoid arthritis. Joint Bone Spine. 2005;72:520–6.
MacGregor AJ, Snieder H, Rigby AS, Koskenvuo M, Kaprio J, Aho K, et al. Characterizing the quantitative genetic contribution to rheumatoid arthritis using data from twins. Arthritis Rheum. 2000;43:30–7.
Silman AJ, Pearson JE. Epidemiology and genetics of rheumatoid arthritis. Arthritis Res Suppl. 2002;4(Suppl 3):265–72.
Vossenaar ER, Zendman AJ, van Venrooij WJ, Pruijn GJ. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays. 2003;25:1106–18.
van der Helm-van Mil AH, Verpoort KN, Breedveld FC, Toes RE, Huizinga TW. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther. 2005;75:R949–58.
Kinloch A, Lundberg K, Wait R, Wegner N, Lim NH, Zendman AJ, et al. Synovial fluid is a site of citrullination of autoantigens in inflammatory arthritis. Arthritis Rheum. 2008;58:2287–95.
Rantapää-Dahlqvist S, de Jong BA, Berglin E, Hallmans G, Wadell G, Stenlund H, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum. 2003;48:2741–9.
Suzuki A, Yamada R, Chang X, Tokuhiro S, Sawada T, Suzuki M, et al. Functional haplotypes of PADI4, encoding citrullinating enzyme peptidylarginine deiminase 4, are associated with rheumatoid arthritis. Nat Genet. 2003;34:395–402.
Harney SM, Meisel C, Sims AM, Woon PY, Wordsworth BP, Brown MA. Genetic and genomic studies of PADI4 in rheumatoid arthritis. Rheumatology (Oxford). 2005;44:869–72.
Hoppe B, Häupl T, Gruber R, Kiesewetter H, Burmester GR, Salama A, et al. Detailed analysis of the variability of peptidylarginine deiminase type 4 in German patients with rheumatoid arthritis: a case–control study. Arthritis Res Ther. 2006;8:R34.
Plenge RM, Padyukov L, Remmers EF, Purcell S, Lee AT, Karlson EW, et al. Replication of putative candidate-gene associations with rheumatoid arthritis in >4,000 samples from North America and Sweden: association of susceptibility with PTPN22, CTLA4, and PADI4. Am J Hum Genet. 2005;77:1044–60.
Martinez A, Valdivia A, Pascual-Salcedo D, Lamas JR, Fernández-Arquero M, Balsa A, et al. PADI4 polymorphisms are not associated with rheumatoid arthritis in the Spanish population. Rheumatology (Oxford). 2005;44:1263–6.
Ikari K, Kuwahara M, Nakamura T, Momohara S, Hara M, Yamanaka H, et al. Association between PADI4 and rheumatoid arthritis: a replication study. Arthritis Rheum. 2005;52:3054–7.
Chen R, Wei Y, Cai Q, Duan S, Ren D, Shen J, et al. The PADI4 gene does not contribute to genetic susceptibility to rheumatoid arthritis in Chinese Han population. Rheumatol Int. 2011;31:1631–4.
Takata Y, Inoue H, Sato A, Tsugawa K, Miyatake K, Hamada D, et al. Replication of reported genetic associations of PADI4, FCRL3, SLC22A4 and RUNX1 genes with rheumatoid arthritis: results of an independent Japanese population and evidence from meta-analysis of East Asian studies. J Hum Genet. 2008;53:163–73.
Iwamoto T, Ikari K, Nakamura T, Kuwahara M, Toyama Y, Tomatsu T, et al. Association between PADI4 and rheumatoid arthritis:a meta-analysis. Rheumatology (Oxford). 2006;45:804–7.
Lee YH, Rho YH, Choi SJ, Ji JD, Song GG. PADI4 polymorphisms and rheumatoid arthritis susceptibility: a meta-analysis. Rheumatol Int. 2007;27:827–33.
Burr ML, Naseem H, Hinks A, Eyre S, Gibbons LJ, Bowes J, et al. PADI4 genotype is not associated with rheumatoid arthritis in a large UK Caucasian population. Ann Rheum Dis. 2010;69:666–70.
Fan LY, Wang WJ, Wang Q, Zong M, Yang L, Zhang H, et al. A functional haplotype and expression of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Chinese. Tissue Antigens. 2008;72:469–73.
Abd-Allah SH, El-Shal AS, Shalaby SM, Pasha HF, El-Saoud AM, El-Najjar AR, et al. PADI4 polymorphisms and related haplotype in rheumatoid arthritis patients. Joint Bone Spine. 2012;79:124–8.
Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–58.
Barton A, Bowes J, Eyre S, Spreckley K, Hinks A, John S, et al. A functional haplotype of the PADI4 gene associated with rheumatoid arthritis in a Japanese population is not associated in a United Kingdom population. Arthritis Rheum. 2004;50:1117–21.
Kang CP, Lee HS, Ju H, Cho H, Kang C, Bae SC. A functional haplotype of the PADI4 gene associated with increased rheumatoid arthritis susceptibility in Koreans. Arthritis Rheum. 2006;54:90–6.
Costenbader KH, Chang SC, De Vivo I, Plenge R, Karlson EW. Genetic polymorphisms in PTPN22, PADI-4, and CTLA-4 and risk for rheumatoid arthritis in two longitudinal cohort studies: evidence of gene–environment interactions with heavy cigarette smoking. Arthritis Res Ther. 2008;10:R52.
Poór G, Nagy ZB, Schmidt Z, Brózik M, Merétey K, Gergely P Jr. Genetic background of anticyclic citrullinated peptide autoantibody production in Hungarian patients with rheumatoid arthritis. Ann N Y Acad Sci. 2007;1110:23–32.
Kochi Y, Thabet MM, Suzuki A, Okada Y, Daha NA, Toes RE, et al. PADI4 polymorphism predisposes male smokers to rheumatoid arthritis. Ann Rheum Dis. 2011;70:512–5.
Feng ZJ, Niu HZ, Liang Y, Niu YL, Wen HF. Association between rheumatoid arthritis and single nucleotide polymorphisms of padi4-104 in Han population in Hebei province. J Mol Diagn Ther. 2010;2:244–7 (in Chinese).
Cui LF, Yang WH, Song HC, Shu R, Han YX, Liu YY, et al. Association of polymorphism of peptidylarginine deiminase 4 gene and rheumatoid arthritis in Han Population. Chin J Allergy Clin Immunol. 2007;1:158–62 (in Chinese).
Zhong B, Fang YF, Li H, Wan P, Yang F, Wang Y. Correlation of peptidylarginine deiminase 4 gene polymorphism and rheumatoid arthritis. J Third Mil Med Univ. 2010;32:1155–7 (in Chinese).
Shi HX, Qian L, Li XP, Li XM, Wang GS, Zhang H. Association of polymorphism of peptidylarginine deaminase-4 gene and rheumatoid arthritis. Chin J Rheumatol. 2010;14:336–9 (in Chinese).
Cui LF, Yuan W, Yang WH, Shu R, Song HC, Han YX, et al. Association of polymorphism of peptidylarginine deiminase 4 (PADI4) gene with rheumatoid arthritis and anti-cyclic citrullinated peptide antibody. Chin J Basic Med Tradit Chin Med. 2011;17:630–2 (in Chinese).
Eyre S, Bowes J, Barton A, Raychaudhuri S, Amos C, Diogo D, et al. An international collaboration for the genetic fine mapping of 8,000 rheumatoid arthritis cases and 12,000 controls refines associations to known loci, indicates multiple independent affects and reveals novel associations. Arthritis Rheum. 2011;63(Suppl 10):1677 (abstract).
Stahl EA, Raychaudhuri S, Remmers EF, Xie G, Eyre S, Thomson BP, et al. Genome-wide association study meta-analysis identifies seven new rheumatoid arthritis risk loci. Nat Genet. 2010;42:508–14.
Acknowledgments
This study was supported by Grants for Scientific Research of BSKY (201018) from Anhui Medical University.
Conflict of interest
None.
Author information
Authors and Affiliations
Corresponding author
Additional information
S. Hou and G. Gao contributed equally to this work.
About this article
Cite this article
Hou, S., Gao, Gp., Zhang, Xj. et al. PADI4 polymorphisms and susceptibility to rheumatoid arthritis: a meta-analysis. Mod Rheumatol 23, 50–60 (2013). https://doi.org/10.1007/s10165-012-0639-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10165-012-0639-4